These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 6850903)
21. Clinical and immunological characteristics of the emulsion form of inactivated influenza vaccine delivered by oral immunization. Avtushenko SS; Sorokin EM; Zoschenkova NY; Zacharova NG; Naichin AN J Biotechnol; 1996 Jan; 44(1-3):21-8. PubMed ID: 8717382 [TBL] [Abstract][Full Text] [Related]
22. [Sensitivity of the ELISA immunoenzyme test for detecting the antibody response of persons vaccinated with an inactivated influenza vaccine]. Proietti E; Rapicetta M; Morace G; Arangio-Ruiz G; Macchia T; Mancini G Ann Ist Super Sanita; 1982; 18(3):521-4. PubMed ID: 7187838 [No Abstract] [Full Text] [Related]
23. [Immunogenicity and safety of domestic slit influenza vaccine]. Zhu XJ; Zhang ZL; Li H; Su X; Guo XH; Chen W; Kou M; Duan WP Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jul; 25(7):644. PubMed ID: 15308057 [No Abstract] [Full Text] [Related]
24. Safety, reactogenicity and immunogenicity of Madin Darby Canine Kidney cell-derived inactivated influenza subunit vaccine. A meta-analysis of clinical studies. Palache AM; Scheepers HS; de Regt V; van Ewijk P; Baljet M; Brands R; van Scharrenburg GJ Dev Biol Stand; 1999; 98():115-25; discussion 133-4. PubMed ID: 10494964 [No Abstract] [Full Text] [Related]
25. [Testing of influenza virus vaccines--an international comparison]. Klett G; Stäber H; Willkommen H Z Gesamte Hyg; 1980; 26(7):473-86. PubMed ID: 7003931 [No Abstract] [Full Text] [Related]
26. Immune responses and protective efficacy in ponies immunised with an equine influenza ISCOM vaccine containing an 'American lineage' H3N8 virus. Crouch CF; Daly J; Hannant D; Wilkins J; Francis MJ Vaccine; 2004 Dec; 23(3):418-25. PubMed ID: 15530689 [TBL] [Abstract][Full Text] [Related]
27. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. King JC; Treanor J; Fast PE; Wolff M; Yan L; Iacuzio D; Readmond B; O'Brien D; Mallon K; Highsmith WE; Lambert JS; Belshe RB J Infect Dis; 2000 Feb; 181(2):725-8. PubMed ID: 10669363 [TBL] [Abstract][Full Text] [Related]
28. Surveillance of the antibody status to current influenza strains in the Norwegian population. 2: Antibodies to the A/USSR/90/77 (H1N1) virus in various age groups after the second epidemic wave. Haaheim LR NIPH Ann; 1980 May; 3(1):49-56. PubMed ID: 7454125 [TBL] [Abstract][Full Text] [Related]
29. Influenza vaccine does not cause rejection after cardiac transplantation. Kobashigawa JA; Warner-Stevenson L; Johnson BL; Moriguchi JD; Kawata N; Drinkwater DC; Laks H Transplant Proc; 1993 Aug; 25(4):2738-9. PubMed ID: 8356730 [No Abstract] [Full Text] [Related]
30. [Inoculation properties of a pediatric variant of adsorbed influenza chemical vaccine]. Berdnikova LF; Vasiaev AI; Pushkarev MA; Vlasov AR; D'iakonova LG Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):48-52. PubMed ID: 3434049 [TBL] [Abstract][Full Text] [Related]
31. Characterization of live influenza vaccine donor strain derived from cold-adaptation of X-31 virus. Lee KH; Seo SU; Song JM; Lee CM; Kim HA; Seong BL Vaccine; 2006 Mar; 24(11):1966-74. PubMed ID: 16343703 [TBL] [Abstract][Full Text] [Related]
32. Design and optimization of a multiplex anti-influenza peptide immunoassay. Drummond JE; Shaw EE; Antonello JM; Green T; Page GJ; Motley CO; Wilson KA; Finnefrock AC; Liang X; Casimiro DR J Immunol Methods; 2008 May; 334(1-2):11-20. PubMed ID: 18329663 [TBL] [Abstract][Full Text] [Related]
33. Epidermal DNA vaccine for influenza is immunogenic in humans. Drape RJ; Macklin MD; Barr LJ; Jones S; Haynes JR; Dean HJ Vaccine; 2006 May; 24(21):4475-81. PubMed ID: 16150518 [TBL] [Abstract][Full Text] [Related]
35. A vaccine prepared from a non-pathogenic H5N1 avian influenza virus strain confers protective immunity against highly pathogenic avian influenza virus infection in cynomolgus macaques. Itoh Y; Ozaki H; Tsuchiya H; Okamoto K; Torii R; Sakoda Y; Kawaoka Y; Ogasawara K; Kida H Vaccine; 2008 Jan; 26(4):562-72. PubMed ID: 18164788 [TBL] [Abstract][Full Text] [Related]
36. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses. Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208 [TBL] [Abstract][Full Text] [Related]
37. The use of inactivated influenza vaccine in children. Wright PF Semin Pediatr Infect Dis; 2006 Oct; 17(4):200-5. PubMed ID: 17055371 [TBL] [Abstract][Full Text] [Related]
38. [Evaluation of the effectiveness of inactivated influenza vaccines by immunological indices]. Unanov SS; Iuminova NV; Akopova II Vopr Virusol; 1984; 29(6):757-60. PubMed ID: 6528581 [No Abstract] [Full Text] [Related]
39. Activity of influenza vaccine against virus strains now circulating. Zuckerman M; Cox R; Oxford J; Taylor J; Wood J; Haaheim L Lancet; 1992 Jan; 339(8785):118. PubMed ID: 1345833 [No Abstract] [Full Text] [Related]
40. Antibody responses to influenza virus vaccine in patients with acute lymphocytic leukaemia. Feery BJ; Matthews RN; Evered MG; Gallichio HA Aust Paediatr J; 1979 Sep; 15(3):177-80. PubMed ID: 293160 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]